Published in Nat Immunol on July 19, 2017
The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer (2012) 10.90
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med (1988) 8.90
The future of immune checkpoint therapy. Science (2015) 5.59
Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat Immunol (2013) 2.23
The emerging role of resident memory T cells in protective immunity and inflammatory disease. Nat Med (2015) 1.69
Programs for the persistence, vigilance and control of human CD8(+) lung-resident memory T cells. Nat Immunol (2016) 1.52
Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. J Exp Med (2007) 1.42
Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer. Clin Cancer Res (2013) 1.30
CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients. J Immunol (2015) 1.17
Innate immune signaling and regulation in cancer immunotherapy. Cell Res (2016) 0.86
The Principles of Engineering Immune Cells to Treat Cancer. Cell (2017) 0.85
Induction of resident memory T cells enhances the efficacy of cancer vaccine. Nat Commun (2017) 0.81
Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma. Oncotarget (2017) 0.80
Programs for the persistence, vigilance and control of human CD8(+) lung-resident memory T cells. Nat Immunol (2016) 1.52
Tissue-resident memory CD8 T cells shape local and systemic secondary T cell responses. Nat Immunol (2020) 0.75
Identification of Functional HLA-A*01 :01-Restricted EBV-LMP2-Specific T-cell Receptors. J Infect Dis (2020) 0.75